{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:38:39Z","timestamp":1781307519254,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NT 13108 \u2013 4"],"award-info":[{"award-number":["NT 13108 \u2013 4"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12883-017-0915-1","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T12:28:37Z","timestamp":1501244917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5892-8464","authenticated-orcid":false,"given":"Helena","family":"Posov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Hor\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e1clav","family":"\u010capek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Uher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenka","family":"Hru\u0161kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Havrdov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,28]]},"reference":[{"issue":"9700","key":"915_CR1","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(09)61259-9","volume":"374","author":"G Comi","year":"2009","unstructured":"Comi G, Martinelli V, Rodegher M, Moiola L, Bajenaru O, Carra A, Elovaara I, Fazekas F, Hartung H, Hillert J. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Lancet. 2009;374(9700):1503\u201311.","journal-title":"Lancet"},{"issue":"6","key":"915_CR2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW. Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald criteria\u201d. Ann Neurol. 2005;58(6):840\u20136.","journal-title":"Ann Neurol"},{"issue":"4","key":"915_CR3","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/j.lpm.2015.03.002","volume":"44","author":"\u00c9 Thouvenot","year":"2015","unstructured":"Thouvenot \u00c9. Update on clinically isolated syndrome. Presse Med. 2015;44(4):e121\u201336.","journal-title":"Presse Med"},{"issue":"3","key":"915_CR4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awm329","volume":"131","author":"L Fisniku","year":"2008","unstructured":"Fisniku L, Brex P, Altmann D, Miszkiel K, Benton C, Lanyon R, Thompson A, Miller D. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain. 2008;131(3):808\u201317.","journal-title":"Brain"},{"issue":"3","key":"915_CR5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1212\/WNL.0000000000000036","volume":"82","author":"R Dobson","year":"2014","unstructured":"Dobson R, Rudick RA, Turner B, Schmierer K, Giovannoni G. Assessing treatment response to interferon-\u03b2 is there a role for MRI. Neurology. 2014;82(3):248\u201354.","journal-title":"Neurology"},{"key":"915_CR6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nicl.2014.09.015","volume":"6","author":"T Uher","year":"2014","unstructured":"Uher T, Horakova D, Bergsland N, Tyblova M, Ramasamy DP, Seidl Z, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R. MRI correlates of disability progression in patients with CIS over 48 months. NeuroImage: Clinical. 2014;6:312\u20139.","journal-title":"NeuroImage: Clinical"},{"issue":"2","key":"915_CR7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.nbd.2009.04.010","volume":"35","author":"H Tumani","year":"2009","unstructured":"Tumani H, Hartung H-P, Hemmer B, Teunissen C, Deisenhammer F, Giovannoni G, Zettl UK, Group BS. Cerebrospinal fluid biomarkers in multiple sclerosis. Neurobiol Dis. 2009;35(2):117\u201327.","journal-title":"Neurobiol Dis"},{"issue":"11","key":"915_CR8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007638","volume":"4","author":"J Brettschneider","year":"2009","unstructured":"Brettschneider J, Tumani H, Kiechle U, Muche R, Richards G, Lehmensiek V, Ludolph AC, Otto M. IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. PLoS One. 2009;4(11):e7638.","journal-title":"PLoS One"},{"issue":"1","key":"915_CR9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jneuroim.2008.04.031","volume":"199","author":"JL Bennett","year":"2008","unstructured":"Bennett JL, Haubold K, Ritchie AM, Edwards SJ, Burgoon M, Shearer AJ, Gilden DH, Owens GP. CSF IgG heavy-chain bias in patients at the time of a clinically isolated syndrome. J Neuroimmunol. 2008;199(1):126\u201332.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"915_CR10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011986","volume":"5","author":"J Brettschneider","year":"2010","unstructured":"Brettschneider J, Czerwoniak A, Senel M, Fang L, Kassubek J, Pinkhardt E, Lauda F, Kapfer T, Jesse S, Lehmensiek V. The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). PLoS One. 2010;5(8):e11986.","journal-title":"PLoS One"},{"issue":"6","key":"915_CR11","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","volume":"66","author":"J Brettschneider","year":"2006","unstructured":"Brettschneider J, Petzold A, S\u00fcssmuth S, Ludolph A, Tumani H. Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology. 2006;66(6):852\u20136.","journal-title":"Neurology"},{"issue":"4","key":"915_CR12","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awq035","volume":"133","author":"M Comabella","year":"2010","unstructured":"Comabella M, Fern\u00e1ndez M, Martin R, Rivera-Vallv\u00e9 S, Borr\u00e1s E, Chiva C, Juli\u00e0 E, Rovira A, Cant\u00f3 E, Alvarez-Cerme\u00f1o JC. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. Brain. 2010;133(4):1082\u201393.","journal-title":"Brain"},{"key":"915_CR13","doi-asserted-by":"crossref","unstructured":"Tintore M, Rovira \u00c0, R\u00edo J, Otero-Romero S, Arrambide G, Tur C, Comabella M, Nos C, Ar\u00e9valo MJ, Negrotto L: Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain 2015:awv105.","DOI":"10.1093\/brain\/awv105"},{"issue":"3","key":"915_CR14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.it.2004.01.007","volume":"25","author":"H Lassmann","year":"2004","unstructured":"Lassmann H, Ransohoff RM. The CD4\u2013Th1 model for multiple sclerosis: a crucial re-appraisal. Trends Immunol. 2004;25(3):132\u20137.","journal-title":"Trends Immunol"},{"key":"915_CR15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","volume":"23","author":"M Sospedra","year":"2005","unstructured":"Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005;23:683\u2013747.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"915_CR16","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/brain\/awl179","volume":"129","author":"L Rinaldi","year":"2006","unstructured":"Rinaldi L, Gallo P, Calabrese M, Ranzato F, Luise D, Colavito D, Motta M, Guglielmo A, Del Giudice E, Romualdi C. Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients. Brain. 2006;129(8):1993\u20132007.","journal-title":"Brain"},{"issue":"3","key":"915_CR17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.21748","volume":"66","author":"H Kebir","year":"2009","unstructured":"Kebir H, Ifergan I, Alvarez JI, Bernard M, Poirier J, Arbour N, Duquette P, Prat A. Preferential recruitment of interferon-\u03b3\u2013expressing TH17 cells in multiple sclerosis. Ann Neurol. 2009;66(3):390\u2013402.","journal-title":"Ann Neurol"},{"issue":"5","key":"915_CR18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.21652","volume":"65","author":"L Durelli","year":"2009","unstructured":"Durelli L, Conti L, Clerico M, Boselli D, Contessa G, Ripellino P, Ferrero B, Eid P, Novelli F. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-\u03b2. Ann Neurol. 2009;65(5):499\u2013509.","journal-title":"Ann Neurol"},{"issue":"8","key":"915_CR19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1212\/WNL.0000000000000146","volume":"82","author":"E Zastepa","year":"2014","unstructured":"Zastepa E, Fitz-Gerald L, Hallett M, Antel J, Bar-Or A, Baranzini S, Lapierre Y, Haegert DG. Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MS. Neurology. 2014;82(8):681\u201390.","journal-title":"Neurology"},{"issue":"6","key":"915_CR20","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/1352458510396922","volume":"17","author":"LM Villar","year":"2011","unstructured":"Villar LM, Espi\u00f1o M, Rold\u00e1n E, Mar\u00edn N, Costa-Frossard L, Muriel A, \u00c1lvarez-Cerme\u00f1o JC. Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes. Mult Scler J. 2011;17(6):690\u20134.","journal-title":"Mult Scler J"},{"issue":"2","key":"915_CR21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292\u2013302.","journal-title":"Ann Neurol"},{"key":"915_CR22","doi-asserted-by":"crossref","unstructured":"Kappos L, De Stefano N, Freedman MS, Cree BA, Radue E-W, Sprenger T, Sormani MP, Smith T, H\u00e4ring DA, Meier DP. Inclusion of brain volume loss in a revised measure of \u2018no evidence of disease activity\u2019(NEDA-4) in relapsing\u2013remitting multiple sclerosis. Mult Scler J. 2015;1352458515616701","DOI":"10.1177\/1352458515616701"},{"issue":"1","key":"915_CR23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-510X(96)00030-5","volume":"139","author":"P Bongioanni","year":"1996","unstructured":"Bongioanni P, Fioretti C, Vanacore R, Bianchi F, Lombardo F, Ambrogi F, Meucci G. Lymphocyte subsets in multiple sclerosis a study with two-colour fluorescence analysis. J Neurol Sci. 1996;139(1):71\u20137.","journal-title":"J Neurol Sci"},{"issue":"7","key":"915_CR24","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","volume":"136","author":"TR Mosmann","year":"1986","unstructured":"Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136(7):2348\u201357.","journal-title":"J Immunol"},{"issue":"2","key":"915_CR25","first-page":"34","volume":"37","author":"CS Constantinescu","year":"2014","unstructured":"Constantinescu CS, Gran B. The essential role of T cells in multiple sclerosis: a reappraisal. Biom J. 2014;37(2):34.","journal-title":"Biom J"},{"key":"915_CR26","doi-asserted-by":"crossref","unstructured":"Raphael I, Nalawade S, Eagar TN, Forsthuber TG. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74(1):5\u201317.","DOI":"10.1016\/j.cyto.2014.09.011"},{"issue":"2","key":"915_CR27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00858721","volume":"240","author":"M Eoli","year":"1993","unstructured":"Eoli M, Ferrarini M, Dufour A, Heltaj S, Bevilacqua L, Comi G, Cosi V, Filippini G, Martinelli V, Milanese C. Presence of T-cell subset abnormalities in newly diagnosed cases of multiple sclerosis and relationship with short-term clinical activity. J Neurol. 1993;240(2):79\u201382.","journal-title":"J Neurol"},{"issue":"5","key":"915_CR28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0404.1995.tb00147.x","volume":"92","author":"M Calopa","year":"1995","unstructured":"Calopa M, Bas J, Mestre M, Arbizu T, Peres J, Buendia E. T cell subsets in multiple sclerosis: a serial study. Acta Neurol Scand. 1995;92(5):361\u20138.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"915_CR29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/clin.1997.4444","volume":"85","author":"D Lehmann","year":"1997","unstructured":"Lehmann D, Karussis D, Mizrachi-Koll R, Linde AS, Abramsky O. Inhibition of the progression of multiple sclerosis by linomide is associated with upregulation of CD4+\/CD45RA+ cells and downregulation of CD4+\/CD45RO+ cells. Clin Immunol Immunopathol. 1997;85(2):202\u20139.","journal-title":"Clin Immunol Immunopathol"},{"issue":"4","key":"915_CR30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000116820","volume":"32","author":"E Kreuzfelder","year":"1992","unstructured":"Kreuzfelder E, Shen G, Bittorf M, Scheiermann N, Thraenhart O, Seidel D, Grosse-Wilde H. Enumeration of T, B and natural killer peripheral blood cells of patients with multiple sclerosis and controls. Eur Neurol. 1992;32(4):190\u20134.","journal-title":"Eur Neurol"},{"issue":"3","key":"915_CR31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neulet.2010.10.036","volume":"487","author":"C Lee-Chang","year":"2011","unstructured":"Lee-Chang C, Z\u00e9phir H, Top I, Dubucquoi S, Trauet J, Prin L, Vermersch P. B-cell subsets up-regulate \u03b14 integrin and accumulate in the cerebrospinal fluid in clinically isolated syndrome suggestive of multiple sclerosis onset. Neurosci Lett. 2011;487(3):273\u20137.","journal-title":"Neurosci Lett"},{"issue":"4","key":"915_CR32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jaut.2011.08.003","volume":"37","author":"J Haas","year":"2011","unstructured":"Haas J, Bekeredjian-Ding I, Milkova M, Balint B, Schwarz A, Korporal M, Jarius S, Fritz B, Lorenz H-M, Wildemann B. B cells undergo unique compartmentalized redistribution in multiple sclerosis. J Autoimmun. 2011;37(4):289\u201399.","journal-title":"J Autoimmun"},{"issue":"11","key":"915_CR33","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1212\/WNL.0b013e318249f6f0","volume":"78","author":"G Disanto","year":"2012","unstructured":"Disanto G, Morahan J, Barnett M, Giovannoni G, Ramagopalan S. The evidence for a role of B cells in multiple sclerosis. Neurology. 2012;78(11):823\u201332.","journal-title":"Neurology"},{"issue":"7","key":"915_CR34","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.4049\/jimmunol.1000271","volume":"186","author":"VS Ramgolam","year":"2011","unstructured":"Ramgolam VS, Sha Y, Marcus KL, Choudhary N, Troiani L, Chopra M, Markovic-Plese S. B cells as a therapeutic target for IFN-\u03b2 in relapsing\u2013remitting multiple sclerosis. J Immunol. 2011;186(7):4518\u201326.","journal-title":"J Immunol"},{"issue":"1","key":"915_CR35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-5728(02)00360-0","volume":"133","author":"O Seidi","year":"2002","unstructured":"Seidi O, Semra Y, Sharief M. Expression of CD5 on B lymphocytes correlates with disease activity in patients with multiple sclerosis. J Neuroimmunol. 2002;133(1):205\u201310.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"915_CR36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2009.08.010","volume":"464","author":"M Niino","year":"2009","unstructured":"Niino M, Hirotani M, Miyazaki Y, Sasaki H. Memory and naive B-cell subsets in patients with multiple sclerosis. Neurosci Lett. 2009;464(1):74\u20138.","journal-title":"Neurosci Lett"},{"issue":"7","key":"915_CR37","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/brain\/awn118","volume":"131","author":"PL Jager De","year":"2008","unstructured":"De Jager PL, Rossin E, Pyne S, Tamayo P, Ottoboni L, Viglietta V, Weiner M, Soler D, Izmailova E, Faron-Yowe L. Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells. Brain. 2008;131(7):1701\u201311.","journal-title":"Brain"},{"issue":"3","key":"915_CR38","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clim.2011.09.006","volume":"141","author":"J Martinez-Rodriguez","year":"2011","unstructured":"Martinez-Rodriguez J, Lopez-Botet M, Munteis E, Rio J, Roquer J, Montalban X, Comabella M. Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis. Clin Immunol. 2011;141(3):348\u201356.","journal-title":"Clin Immunol"},{"issue":"1","key":"915_CR39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jneuroim.2012.08.009","volume":"254","author":"I Hamann","year":"2013","unstructured":"Hamann I, D\u00f6rr J, Glumm R, Chanvillard C, Janssen A, Millward JM, Paul F, Ransohoff RM, Infante-Duarte C. Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation. J Neuroimmunol. 2013;254(1):165\u20139.","journal-title":"J Neuroimmunol"},{"issue":"15","key":"915_CR40","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1073\/pnas.0601335103","volume":"103","author":"B Bielekova","year":"2006","unstructured":"Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann TA, McFarland H, Henkart PA, Martin R. Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2R\u03b1-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci. 2006;103(15):5941\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"915_CR41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10072-007-0803-3","volume":"28","author":"M Saraste","year":"2007","unstructured":"Saraste M, Irjala H, Airas L. Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta. Neurol Sci. 2007;28(3):121\u20136.","journal-title":"Neurol Sci"},{"issue":"1","key":"915_CR42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2009.08.007","volume":"215","author":"AA Vandenbark","year":"2009","unstructured":"Vandenbark AA, Huan J, Agotsch M, La Tocha D, Goelz S, Offner H, Lanker S, Bourdette D. Interferon-beta-1a treatment increases CD56 bright natural killer cells and CD4+ CD25+ Foxp3 expression in subjects with multiple sclerosis. J Neuroimmunol. 2009;215(1):125\u20138.","journal-title":"J Neuroimmunol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-017-0915-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T19:02:32Z","timestamp":1692903752000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-017-0915-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,28]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["915"],"URL":"https:\/\/doi.org\/10.1186\/s12883-017-0915-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,28]]},"article-number":"145"}}